Amphastar Pharmaceuticals AMPH Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's free cash flow yield?
- Amphastar Pharmaceuticals (AMPH) reported free cash flow yield of 15.2% in Q1 2026.
- How has Amphastar Pharmaceuticals's free cash flow yield changed year-over-year?
- Amphastar Pharmaceuticals's free cash flow yield increased by 39.9% year-over-year, from 10.9% to 15.2%.
- What is the long-term trend for Amphastar Pharmaceuticals's free cash flow yield?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's free cash flow yield has grown at a 32.3% compound annual growth rate (CAGR), from 2.4% to 9.9%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.